Back to STATE STREET CORP STATE STREET CORP

ELDNELDN
Showing 8 of 21 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in ELEDON PHARMACEUTICALS INC

Yes. State Street holds 1,621,969 shares of ELDN (Eledon Pharmaceuticals), worth $6.4M, as of its Q2 2026 13F filing. It increased the position by 467,298 shares (+40.5%) from Q1 2026. State Street has held ELDN since Q2 2021, across 21 quarterly 13F filings.

Current Value

$6.4M

Current Shares

1.6M

Total Value Change

+$6M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+40.5%
$6.4M0.0%$3.94
36
2026-Q1
Increased
1.2M
+49.2%
$3.6M0.0%$2.50
37
2025-Q4
Increased
773,885
+18.1%
$1.2M0.0%$1.51
20
2025-Q3
Increased
655,476
+8.3%
$1.7M0.0%$2.54
28
2025-Q2
Increased
605,340
+184.1%
$1.6M0.0%$2.69
41
2025-Q1
Increased
213,101
+14.0%
$722,4120.0%$3.35
19
2024-Q4
Increased
187,001
+15.8%
$770,4440.0%$4.14
19
2024-Q3
Unchanged
161,492
0.0%
$402,1150.0%$2.49
0

Other major holders of ELDN: BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., FMR LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used